Charles River Laboratories International Accounts Payable

Charles River Laboratories International (CRL) currently reports a accounts payable of $140M as of June 2026. That compares with $150M in the prior-year period — down 3.3% year over year. Use the charts on this page to explore Charles River Laboratories International's accounts payable history and peer comparisons.

Charles River Laboratories International's accounts payable decreased from $150M to $140M — a 3.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Charles River Laboratories International reported $140M in accounts payable as of June 2026. That compares with $150M in the prior-year period — down 3.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $140M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Charles River Laboratories International, and consider following CRL for alerts when major investors trade the stock.

Charles River Laboratories International is classified in the Healthcare sector. On accounts payable, it currently shows $140M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CRL with unrelated industries.